Contrave vs Mounjaro
Side-by-side comparison of Contrave (naltrexone HCl + bupropion HCl ER) and Mounjaro (tirzepatide (T2D injection)) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Contrave
Based on the data below, Contrave wins on lower cash price ($650/mo vs $1069/mo). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
Contrave
naltrexone HCl + bupropion HCl ER · Nalpropion Pharmaceuticals (Currax Pharmaceuticals)
Mounjaro
tirzepatide (T2D injection) · Eli Lilly and Company
| Field | Contrave | Mounjaro |
|---|---|---|
| Route | tablet · daily | injection · weekly |
| Avg weight loss | 5–9% | 12–16% |
| Food restriction | Avoid high-fat meals | No food restriction |
| Cash from | $650/mo | $1069/mo |
| Savings card | — | — |
| Medicare Bridge | Tier 3 | Tier 4 |
| A1c reduction | — | −2.4% |
| FDA approved | 2014-09 | 2022-05 |
- RouteContravetablet · dailyMounjaroinjection · weekly
- Avg weight lossContrave5–9%Mounjaro12–16%
- Food restrictionContraveAvoid high-fat mealsMounjaroNo food restriction
- Cash fromContrave$650/moMounjaro$1069/mo
- Savings cardContrave—Mounjaro—
- Medicare BridgeContraveTier 3MounjaroTier 4
- A1c reductionContrave—Mounjaro−2.4%
- FDA approvedContrave2014-09Mounjaro2022-05
Pick Contrave if…
- Cash pay matters more than peak weight loss ($650/mo cheaper)
- You're needle-averse
Pick Mounjaro if…
- You can't reliably do a fasting window before meds
- You want the higher peak efficacy (16% vs 9%)
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.